Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Sep 12, 2023 04:05
Trevi Therapeutics | EFFECT: Others
Aug 16, 2023 12:15
Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Jun 13, 2023 04:47
Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 11, 2023 23:44
Trevi Therapeutics | 424B5: Prospectus
Sep 24, 2022 05:22
Trevi Therapeutics | 424B5: Prospectus
Sep 23, 2022 04:06
Trevi Therapeutics | 424B5: Prospectus
May 14, 2022 06:27
Trevi Therapeutics | EFFECT: Others
May 12, 2022 12:15
Trevi Therapeutics | EFFECT: Others
Nov 17, 2021 13:15
Trevi Therapeutics | EFFECT: Others
Oct 26, 2021 12:15
Trevi Therapeutics | EFFECT: Others
Jul 15, 2021 12:15
Trevi Therapeutics | 424B3: Prospectus
Jul 15, 2021 05:05
Trevi Therapeutics | EFFECT: Others
Jul 6, 2020 12:15
Trevi Therapeutics | 424B3: Prospectus
Jul 3, 2020 04:26
Trevi Therapeutics | 424B4: Prospectus
May 9, 2019 04:02
Trevi Therapeutics | EFFECT: Others
May 8, 2019 12:16
Trevi Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
May 8, 2019 01:32
Trevi Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange
Apr 29, 2019 22:32
No Data
No Data